Table 2. TCR-Vβ use in cord-blood... | American Society of Hematology

Table 2.

TCR-Vβ use in cord-blood mononuclear cells of uninfected (mean % ± SEM, n = 6-9) or congenitally infected newborns (individual data of 3 newborns)

	CD8⁺ T cells				CD4⁺ T cells
	Uninfected newborns	Congenitally infected newborns			Uninfected newborns	Congenitally infected newborns
	Uninfected newborns	1	2	3	Uninfected newborns	1	2	3
Vβ3	5.8 ± 1.0^*	0.7	1.2	6.6	4.9 ± 0.8	7.6	4.2	2.5
Vβ5	3.2 ± 0.2	7.5^†	3.5	2.4	2.2 ± 0.1	3.4^†	2.6	1.6
Vβ11	0.8 ± 0.1	1.1	0.6	0.8	0.8 ± 0.0	2.0^†	1.0^†	0.6
Vβ13.1	3.4 ± 0.3	13.5^†	13.5^†	2.8	3.4 ± 0.3	7.1^†	3.4	2.8
Vβ14	6.8 ± 0.7	9.0	4.5	4.1	2.9 ± 0.1	2.4	3.0	2.5
Vβ16	0.8 ± 0.1	0.8	0.6	1.2^†	0.7 ± 0.1	0.3	0.9	0.5
Vβ17	5.6 ± 0.6	23.9^†	3.0	5.2	5.1 ± 0.2	5.3	4.6	3.8
Vβ18	0.6 ± 0.2	1.4	0.3	0.2	0.8 ± 0.1	1.5^†	1.1	0.8
Vβ22	4.5 ± 0.6	1.1	11.7^†	2.2	3.9 ± 0.4	5.5	5.1	4.0

	CD8⁺ T cells				CD4⁺ T cells
	Uninfected newborns	Congenitally infected newborns			Uninfected newborns	Congenitally infected newborns
	Uninfected newborns	1	2	3	Uninfected newborns	1	2	3
Vβ3	5.8 ± 1.0^*	0.7	1.2	6.6	4.9 ± 0.8	7.6	4.2	2.5
Vβ5	3.2 ± 0.2	7.5^†	3.5	2.4	2.2 ± 0.1	3.4^†	2.6	1.6
Vβ11	0.8 ± 0.1	1.1	0.6	0.8	0.8 ± 0.0	2.0^†	1.0^†	0.6
Vβ13.1	3.4 ± 0.3	13.5^†	13.5^†	2.8	3.4 ± 0.3	7.1^†	3.4	2.8
Vβ14	6.8 ± 0.7	9.0	4.5	4.1	2.9 ± 0.1	2.4	3.0	2.5
Vβ16	0.8 ± 0.1	0.8	0.6	1.2^†	0.7 ± 0.1	0.3	0.9	0.5
Vβ17	5.6 ± 0.6	23.9^†	3.0	5.2	5.1 ± 0.2	5.3	4.6	3.8
Vβ18	0.6 ± 0.2	1.4	0.3	0.2	0.8 ± 0.1	1.5^†	1.1	0.8
Vβ22	4.5 ± 0.6	1.1	11.7^†	2.2	3.9 ± 0.4	5.5	5.1	4.0

Mean percentage of positive cells ± SEM.

Values higher than the normal upper range (mean ± 2 SD of uninfected newborns).